Factors associated with the development of disability due to leprosy in the province of Chaco 2009-2019

Authors

  • Emanuel Da Luz “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco
  • Gonzalo Anriquez “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco
  • Lía Valeria Zini “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco
  • Vanesa Lisa Melo “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco
  • Viviana Lorena Escobar Solari “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco
  • María Estela Fiad “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco
  • Baltazar Ángel Paniagua “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco
  • Sebastián Genero Julio Cecilio Perrando Hospital, Chaco, Chaco
  • Manuel Fernando Giménez “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco

DOI:

https://doi.org/10.47196/da.v30i3.2669

Keywords:

leprosy, Hansen’ disease, Mycobacterium leprae, Mycobacterium lepromatosis, disability, Chaco

Abstract

Introduction: leprosy is a chronic infectious and contagious disease caused, in most cases, by the Mycobacterium Leprae bacillus, and by Mycobacterium lepromatosis as a second casual agent, which predominantly affects the skin, peripheral  nerves and, sometimes, internal organs. Of the new 10.813 cases detected in 2019, 5,3% was with grade 2 disability. Although the rate of prevalence in Argentina and in the province of Chaco is lower than 1/100.000 inhabitants, the disability detected among new cases of leprosy, estimated between 10 and 40%, is an object of concern.

Objectives: to describe the disabilities and the associated factors caused by leprosy in all the cases reported in the province of Chaco from 2009 to 2019 in order to identify risk groups and to implement more effective healthcare policies to overcome this problem.

Materials and methods: transversal, correlational and retrospective cohort study. A survey of patients detected in the province of Chaco (Argentina) over the course of 11 years was carried out (2009-2019). The statistical techniques used were descriptive and of verification of differences (mean, medium, rank, percentage, student’s t and chi-square tests).

Results: it could be observed that of a total of 377 patients having leprosy in the province of Chaco and who were admitted to the provincial program from the year 2009 to 2019, 175 (46,4%) had disability while 202 (53,6%) patients did not. Considering the patients with disability, 175 (46,4%), the risk factors with statistical relevance were the following: 65,14% of patients (p:0,006), were males; as regards clinical forms, 95,43% of patients (p=0,0001) had multibaciliary forms; 41,95% (p=0,001) had borderline leprocy and 51,72% of the patients had a lepromatous form of the disease; 46,24% of the patients had reactive episodes with disability with a statistically significant difference (p=0.0002).

Conclusions: the statistical significance of risk factors identified were: male sex, bacillary load, lepromatous form, and the occurrence of reactive episodes. The obtained information is relevant to introduce more efficient measures and for further research in the field.

Author Biographies

Emanuel Da Luz, “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco

Head of Dermatology Residents, Dermatology

Gonzalo Anriquez, “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco

Staff Physician, Professor and Instructor of Dermatology, Dermatology

Lía Valeria Zini, “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco

Staff Physician, Professor and Instructor of Dermatology, Dermatology

Vanesa Lisa Melo, “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco

Staff Physician, Professor and Instructor of Dermatology, Dermatology

Viviana Lorena Escobar Solari, “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco

Staff Physician, Professor and Instructor of Dermatology, Dermatology

María Estela Fiad, “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco

Professor and Instructor of Dermatology, Dermatology

Baltazar Ángel Paniagua, “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco

Coordinator of the Leprosy Program, Director of the Residency and the Dermatology Service, Dermatology

Sebastián Genero, Julio Cecilio Perrando Hospital, Chaco, Chaco

Epidemiologist

Manuel Fernando Giménez, “Dr. Manuel M. Giménez” Dermatology Center, Chaco, Chaco

Consultant at the “Dr. Manuel M. Giménez” Dermatology Center

References

I. Deps P, Collin SM. Mycobacterium lepromatosis as a second agent of Hansen’s disease. Front Microbiol. 2021;12:698588.

II. World health Organization. Global leprosy (Hansen disease) update 2019: time tostep-up prevention initiatives. Relevé Épid Hebdom 2020;36(4):417-440.

III. Santana-Santos V, Santos de Matos A, Alves de Oliveira L, Dolce de Lemos L, et ál. Variables clínicas asociadas con discapacidad en casos de Lepra en el noreste de Brasil. J Infect Dev Ctries. 2015;9:232-238.

IV. Shumet T, Demissie M, Bekele Y. Prevalencia de factores asociados con discapacidad registrados en pacientes con Lepra de toda África también en rehabilitación en Lepra en Centro de entrenamiento Addis Ababa, Ethiopia Ethiop. J Health Sci. 2015;25:313-320.

V. Rezende da Silva J, Palmeira J, Moita Sa A y Vidal Noguera L. Factores sociodemográficos asociados con el grado de incapacidad física en la Lepra. Rev Cuid 2018;9:2338-2348.

VI. Ganesan D, Muthunarayanan L. Is disability in leprosy still a burden? A cross-sectional study in a rural block in Tamil Nadu, India. Trans R Soc Trop Med Hyg. 2018;112:31-35.

VII. Srinivas G, Thirumugam M, Vivek L, Kanagasabapathy V, et ál. Riesgo de discapacidad en casos de adultos con Lepra en 5 estados de la India: un estudio de casos y controles. Plos Neglected Tropical Diseases 2019;13:1-1.

VIII. Reyila W, Betsy A, Riyaz N, Sasidharanpillai S, et ál. Clinico-epidemiological study of disability due to leprosy at the time of diagnosis among patients attending a tertiary care institution. Indian J Dermatol. 2019;64:106-111.

IX. Simionato de Assis I, Zamboni-Berra T, Alves L, Viera-Ramos A, et ál. Leprosy in urban space, áreas of risk for disability and worseninig of this health condition in Foz Do Iguacu, the border region between Brazil, Paraguay and Argentina. BMC Public Health 2020;20:1-12.

X. Chen X, Hong-bing Liu, Tie-jun Shul, Shun Zha. Risk factors for physical disability in patients with leprosy disease in Yunnan, China: Evidence from a retrospective observational study. Plos Neglected Tropical Diseases. 2021;13:1-14.

XI. Gomes da Cruz Silva M, Pinheiro Costa e Silva S, do Carmo R, Dornels Freire de Souza C, et ál. Epidemiological of leprosy in Juazeiro-BA from 2002 to 2012 An Bras Dermatol. 2015;90:799-805.

XII. Freire de Santana E, Krystine-Gonçalves de Brito K, Missias-Vilaverde Antas E, de Almeida Nogueira J. Factors associated with the development of physical disabilities in Hansen’s disease. Rev Inst Mey et áld Trop São Paulo 2018;60:1-17.

XIII. de Paula H, de Souza C, Silva S, Martins-Filho P, et ál. Risk factors for physical disability in patients with leprosy. A systematic review and meta-analysis. JAMA Dermatol. 2019;155:1120-1128.

Published

2024-10-21

Issue

Section

Original Articles